Investors

Investors image

News

Nov.12, 2025 Release
Shionogi Launches XOFLUZA® Granules 2% – New Formulation for Influenza Treatment and Prophylaxis
Nov.05, 2025 Release
New Clinical Data on the Efficacy of Antiviral Treatments for Post-COVID-19 Condition
Nov.04, 2025 Notice
Notice Regarding Interim Dividend for the Fiscal Year Ending March 31, 2026
Nov.04, 2025 Release
Shionogi Pharma’s Kanegasaki Plant Receives “BSI Kitemark™ for Minimized Risk of AMR” Certification for Antimicrobial Manufacturing
Oct.31, 2025 Notice
Notice of Commencement of Operations at Our New Headquarters
  • Latest IR Information

    ・Financial Results / Supplement

    　- Presentation material

    　- Transcript

    more
  • IR Library

    ・Financial Results / Supplement

    ・Presentation materials

    ・Annual Report / Integrated Report / EHS Report

    ・Corporate Governance Report

    ・Pipeline

    ・Fact Book

    more
  • Management Policy

    ・Philosophy

    ・Business Plan

    ・Corporate Governance

    ・Disclosure Policy

    ・Business Risks

    more
  • Shareholder Information

    ・Information on Shares

    ・General Meeting of Shareholders

    ・Analyst Coverage

    ・Bonds & Ratings

    more
  • Individual Investors

    ・Pharmaceutical Business

    ・Shionogi's Strength

    ・Business Strategy

    ・Business Activities, etc.

     

    more
  • Sustainability

    View the Shionogi's approach to sustainable growth

    more
  • Financial Highlights

    Financial highlights for the last five years

    more
  • IR Calendar

    The schedule and results of IR events in each fiscal year

     

    more